Related references
Note: Only part of the references are listed.5-HT1B receptors and aggression:: A review
B Olivier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults
SB Clausen et al.
CNS SPECTRUMS (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
Effects of memantine on behavioural symptoms in Alzheimer's disease patients:: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
S Gauthier et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration
L Liang et al.
FEBS LETTERS (2004)
Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction
V Senanarong et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease
S Tekin et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
